Quantitative Anterior Segment SD-OCT Assessment of the Iridocorneal Angle in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension: An Observational Study

定量前节SD-OCT评估中国开角型青光眼或高眼压患者虹膜角膜角:一项观察性研究

阅读:2

Abstract

PURPOSE: We evaluated iridocorneal angle biometrics using anterior segment spectral-domain optical coherence tomography (SD-OCT) compared with Shaffer grade clinical assessments in Chinese patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) to determine which method is most suitable for preoperative angle assessment. METHODS: This noninterventional, prospective study enrolled 206 patients with OAG or OHT in both eyes and Shaffer grade >1 iridocorneal angles at 3 sites in China. Shaffer grades and SD-OCT 5-line raster scans (Zeiss Cirrus HD-OCT 4000) of the inferior angle were obtained under dark conditions. Images were evaluated for visualization of Schwalbe's line, the superior iris surface, and angle recess. ImageJ software was used to measure the angle-opening distance at Schwalbe's line (SL-AOD) in gradable images. RESULTS: Almost all study eyes had Shaffer grade 4 (91.0%) or grade 3 (8.3%) angles. Mean (standard deviation) SL-AOD was 0.75 (0.33) mm (median 0.73, range 0.051-1.9, n=322). The SL-AOD was <0.635 mm (the tube outer diameter of the Ahmed glaucoma valve and Baerveldt glaucoma implant) in 37.6% of the eyes. SL-AOD values did not differ significantly between OAG and OHT diagnoses or between phakic and pseudophakic eyes. CONCLUSION: Iridocorneal angle biometrics derived from SD-OCT images in Chinese patients with OAG or OHT showed large variation in the SL-AOD in eyes with open angles on gonioscopy. Over one-third of patients had SL-AOD too small to safely accommodate commonly used glaucoma tube shunts. Expanded preoperative use of SD-OCT could potentially be beneficial to detect angles at risk for corneal complications and inform device selection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。